CSL Ltd. — Director's Dealing 2024

Nov 4, 2024

For immediate release

==> picture [596 x 198] intentionally omitted <==

5 November 2024

APPENDIX 3Y – CHANGE IN DIRECTOR’S INTEREST

The attached Appendix 3Y relates to changes in the relevant interest in the Company’s securities held by the Chief Executive Officer (CEO) of CSL Limited, Dr Paul McKenzie.

A grant of Performance Share Units has been made to Dr McKenzie following approval from shareholders at CSL’s Annual General Meeting held on 29 October 2024.

Following approval through CSL’s governance processes, Dr McKenzie has also sold shares from Long-Term Incentive (LTI) awards that have vested from grants made under CSL’s remuneration plan.

The sale was made to meet taxation obligations and for portfolio diversification purposes.

Following these transactions, Dr McKenzie continues to hold a significant interest in the Company’s securities, comprising 22,952 ordinary shares. This represents a shareholding of approximately 230% of his base salary.

Dr McKenzie remains on track to achieve CSL’s minimum guideline for its Chief Executive Officer which is to hold shares worth three times base salary within five years of appointment - a reflection of the Company’s remuneration model that links executive pay to the continued achievement of CSL’s long-term strategy.

Authorised for lodgment by:

Fiona Mead Company Secretary

For further information, please contact:

Investors:

Media:

Chris Cooper Bernard Ronchi Stephen McKeon Jimmy Baker Head, Investor Relations Director, Investor Relations Director, Investor Relations Communications CSL Limited CSL Limited CSL Limited CSL Limited P: +61 455 022 740 P: +61 3 9389 3470 P: 61 402 231 696 P: +61 450 909 211 E: chris.cooper@csl.com.au E: bernard.ronchi@csl.com.au E: stephen.mckeon@csl.com.au E: jimmy.baker@csl.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CSL Limited ABN 99 051 588 348

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Paul McKenzie
Date of last notice	5 September 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Solium Nominees (Australia) Pty Ltd as custodianfor the CSL Limited Performance Rights Plan (thePlan)
Date of change	30 October 2024 and 31 October 2024
No. of securities held prior to change	Direct:Nil.Indirect:65,457 Performance Share Units held bySolium Nominees (Australia) Pty Ltd as custodianfor the CSL Limited Performance Rights Plan (thePlan).26,952 Ordinary Shares held bySolium Nominees (Australia) Pty Ltd as custodianfor the CSL Limited Performance Rights Plan (thePlan).

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	•Ordinary Shares•Performance Share Units under the CSLLimited Performance Rights Plan (the**Plan**).Subject to satisfaction of certain performancehurdles and the other rules of the Plan, eachPerformance Share Unit carries the right tosubscribe for or acquire one ordinary share inCSL Limited.
Number acquired	38,065 Performance Share Units (30 October 2024)
Number disposed	4,000 Ordinary Shares (31 October 2024)
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	No consideration was paid or received for the grantof Performance Share Units.Consideration received from the sale of 4,000Ordinary Shares was $1,148,600.00 (being 4,000Ordinary Shares at a price of $287.15).
No. of securities held after change	Direct:Nil.Indirect:103,522 Performance Share Units held bySolium Nominees (Australia) Pty Ltd as custodianfor the CSL Limited Performance Rights Plan (thePlan).22,952 Ordinary Shares held bySolium Nominees (Australia) Pty Ltd as custodianfor the CSL Limited Performance Rights Plan (thePlan).
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Grant of Performance Share Units pursuant to thePlan as a long term incentive for Dr McKenzie asapproved by shareholders at the 2024 AnnualGeneral Meeting.4,000 Ordinary Shares – On market trade fortaxation obligations and portfolio diversification.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	No
Nature of interest

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?
If prior written clearance was provided, on what date was thisprovided?

Fiona Mead Company Secretary 5 November 2024

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3